Novartis AG

NOVN.SW · Moat type: REGULIERUNG

MoatScore

8/10

Fair Value

212 CHF (≈ 261.62 USD)

Margin of Safety

+41.8 %

Rating

STARK

Novartis AG is a global pharmaceutical company that generates revenues through a focused portfolio of patent-protected medicines in areas such as oncology, cardiovascular, immunology, and neurology, by converting research investments into regulatory-protected blockbuster active ingredients with sustained pricing power.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.